Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication-Reference-Cited by-同舟云学术

Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication

Published:2020-05-05 Issue:16 Volume:26 Page:4260-4267
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Weiss Jared,Sheth Siddharth,Deal Allision M.^ORCID,Grilley Olson Juneko E.^ORCID,Patel Samip,Hackman Trevor G.,Blumberg Jeffrey M.,Galloway Thomas J.,Patel Shetal,Zanation Adam M.,Shen Colette J.^ORCID,Hayes D. Neil^ORCID,Hilliard Christopher,Mehra Ranee^ORCID,McKinnon Karen P.,Wang Hsing-Hui^ORCID,Weissler Mark Christian^ORCID,Bauman Jessica R.,Chera Bhishamjit S.,Vincent Benjamin G.^ORCID

Funder

AACRAstraZenecaMedImmuneAstraZenecaMedImmune

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic viruses facilitate tumor immunotherapy;SCIENTIA SINICA Vitae;2024-09-01

2. Treatment options for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma: a systematic review;Journal of Cancer Research and Clinical Oncology;2024-08-02

3. Development and Validation of a Pathomics Model Using Machine Learning to Predict <i>CXCL8</i> Expression and Prognosis in Head and Neck Cancer;Clinical and Experimental Otorhinolaryngology;2024-02-29

4. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study;Cancer Medicine;2024-01-21

5. The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles;Environmental Research;2024-01